Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque (PHYTOPLAQUES)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69677
- Hôpital Cardio-Vasculaire et Pneumologique Louis Pradel
-
Nantes, France, 44093
- Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition
-
Paris, France, 75013
- Groupe Hospitalier Pitié-Salpêtrière, Endocrinology and Metabolism Department
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient, men and women, aged between 40 to 75 ans (limits included) willing to participate to the study and have signed informed consent for its participation in the study
Displaying a non serious chirurgical indication of clinical asymptomatic carotid stenosis defined by:
- atherosclerotic stenosis of 60 to 75% on one on the two carotid junction (external carotid excluded) according to criteria from NASCET
- without constituted or transitory recent cerebral vascular accident. The discovery of an ischaemic after-effect on a systematic scanner is not a criterion of exclusion
- Subject with normal body weight or in over weight (Body Mass Index ranged between 19 and 30 kg/m2, [limits included])
- Subject willing to follow dietary recommendations advised during hypercholesterolemia (according to AFSSAPS' recommendations)
- Subject with social insurance or equivalent.
Exclusion Criteria:
- Subject who, according to AFSSAPS' recommendations, should received a hypocholesterolemic therapy before the end of the study.
- Subject with a history of diabetes
- Subject with cardiac disease such as unstable angina, myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, or moderate or severe congestive heart failure within the last 6 months.
- Subject with plasma triglyceride levels higher than 2,5 g/l [limit included],
- Subject taking any drugs known to affect the evaluation of studied parameters
- Subject with severe or acute disease that could affect the results of the study or subject safety
- Subject with regular consumption of phytosterol enriched foods products during the study.
- Subject with any other medical condition or laboratory abnormality prior to recruitment that in the opinion of the principal investigator could affect subject safety or render unlikely trial to be conducted to the end.
- For women: pregnancy or breast feeding or subject likely to be pregnant during the study.
- For women: subject likely to modify their hormonal therapy during the study
- Subject in exclusion period after its participation in an other clinical trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 1
plant sterol enriched margarine
|
Each group will have to consume 20 grams of margarines (either placebo or enriched in plant sterols) in one or two catches per day, for 8 weeks.
|
|
Placebo Comparator: 2
placebo margarine
|
Each group will have to consume 20 grams of margarines (either placebo or enriched in plant sterols) in one or two catches per day, for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Eric BRUCKERT, PU PH, APHP
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2006-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.